Frontiers Association of Lipoprotein(a)-Associated Mortality and

Frontiers Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology

Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks – Consult QD

A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies - ScienceDirect

Frontiers Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study

Frontiers Lipoprotein(a) in Cardiovascular Diseases: Insight From a Bibliometric Study

Lipoprotein(a) - Wikipedia

Frontiers The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

Genome-Wide Association Study and Identification of a Protective Missense Variant on Lipoprotein(a) Concentration

Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease - ScienceDirect